Cargando…

Short‐term changes in pancreatic α‐cell function after the onset of fulminant type 1 diabetes

Detalles Bibliográficos
Autores principales:	Takahashi, Nobuyuki, Chujo, Daisuke, Tsujimoto, Tetsuro, Kajio, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934243/ https://www.ncbi.nlm.nih.gov/pubmed/29750106 http://dx.doi.org/10.1111/jdi.12706

Ejemplares similares

High risk of renal dysfunction in patients with fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2017)

Response to “Preserved” glucagon secretion in fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Improvement of glycemic control without severe hypoglycemia in a type 1 diabetes patient undergoing hemodialysis after a change from insulin glargine to insulin degludec
por: Takahashi, Nobuyuki, et al.
Publicado: (2016)

Contribution of pancreatic α‐cell function to insulin sensitivity and glycemic variability in patients with type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Insulinoma Presenting with Reactive Hypoglycemia: Evaluating the Effect of Tumor Resection via Continuous Glucose Monitoring
por: Kikuchi, Tomohiko, et al.
Publicado: (2017)

Favourable changes in mortality in people with diabetes: US NHANES 1999–2010
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Poorly controlled type 2 diabetes with no progression of diabetes-related complications and low levels of advanced glycation end products: A Case report
por: Nakamura, Tomoka, et al.
Publicado: (2019)

Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy
por: Shigemoto, Ryo, et al.
Publicado: (2018)

Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Optimal cardiac strategy based on the history of myocardial infarction in type 2 diabetic patients with coronary artery disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes using non‐steroidal anti‐inflammatory drugs
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm Study
por: Ueno, Keisuke, et al.
Publicado: (2020)

Familial Creutzfeldt-Jakob Disease with early onset myoclonus: A case for fulminant progression
por: Naskar, Indira, et al.
Publicado: (2023)

Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018)

Intensive Blood Pressure Treatment for Resistant Hypertension: Secondary Analysis of a Randomized Controlled Trial
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Thiazide Use and Decreased Risk of Heart Failure in Nondiabetic Patients Receiving Intensive Blood Pressure Treatment
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020)

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020)

Effects of β‐blockers on all‐cause mortality in patients with type 2 diabetes and coronary heart disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Obesity, diabetes, and length of time in the United States: Analysis of National Health and Nutrition Examination Survey 1999 to 2012
por: Tsujimoto, Tetsuro, et al.
Publicado: (2016)

Amylase α-2A Autoantibodies: Novel Marker of Autoimmune Pancreatitis and Fulminant Type 1 Diabetes
por: Endo, Toyoshi, et al.
Publicado: (2009)

“Preserved” glucagon secretion in fulminant type 1 diabetes
por: Murase‐Mishiba, Yuko, et al.
Publicado: (2018)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Case of fulminant type 1 diabetes with coronary microcirculatory dysfunction
por: Yamada, Hodaka, et al.
Publicado: (2014)

Glucagon secretions are impaired in patients with fulminant type 1 diabetes
por: Komada, Hisako, et al.
Publicado: (2019)

Fulminant type 1 diabetes after COVID-19 vaccination
por: Tang, Xiaohan, et al.
Publicado: (2022)

Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population‐based observational study
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Fulminant Supraglottitis from Neisseria meningitidis
por: Kortepeter, Mark G., et al.
Publicado: (2007)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

A pitfall in hemoglobin A1c measurement with high performance liquid chromatography method in the diagnosis of onset of fulminant type 1 diabetes mellitus
por: Oe, Yasuharu, et al.
Publicado: (2022)

Analysis of pancreatic volume in acute‐onset, slowly‐progressive and fulminant type 1 diabetes in a Japanese population
por: Sasamori, Hiroto, et al.
Publicado: (2018)

Fulminant Cytotoxic Edema in a Patient with Pneumococcal Meningoencephalitis
por: Alonso, Angelika, et al.
Publicado: (2019)

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)
por: Imagawa, Akihisa, et al.
Publicado: (2012)

Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes
por: Nakamura, Tomoka, et al.
Publicado: (2023)

Case of fulminant type 1 diabetes mellitus associated with parvovirus B19 infection
por: Nishiumi, Tomoko, et al.
Publicado: (2014)

Nivolumab‐induced fulminant type 1 diabetes with precipitous fall in C‐peptide level
por: Miyauchi, Masaaki, et al.
Publicado: (2019)

Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Acute fulminant eosinophilic myocarditis due to Giardia lamblia infection
por: Beuy, Joob, et al.
Publicado: (2019)

Rapid visual loss associated with fulminant idiopathic intracranial hypertension
por: Saraswat, Neeraj, et al.
Publicado: (2019)

Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Wiwanitkit, Viroj
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l3tuobcsb639fmnbo7pla0ujf0